Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II-Reference-Cited by-同舟云学术

Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II

Published:2013-10-15 Issue:12 Volume:5 Page:1871-1886
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Kollmann Katrin¹,Pestka Jan Malte²,Kühn Sonja Christin²,Schöne Elisabeth¹,Schweizer Michaela³,Karkmann Kathrin¹,Otomo Takanobu¹,Catala‐Lehnen Philip²,Failla Antonio Virgilio⁴,Marshall Robert Percy²,Krause Matthias²,Santer Rene¹,Amling Michael²,Braulke Thomas¹,Schinke Thorsten²

Affiliation:

1. Department of BiochemistryChildren's HospitalUniversity Medical Center Hamburg‐EppendorfHamburgGermany

2. Department of Osteology and BiomechanicsCenter of Experimental MedicineUniversity Medical Center Hamburg‐EppendorfHamburgGermany

3. Department of Electron MicroscopyCenter for Molecular NeurobiologyUniversity Medical Center Hamburg‐EppendorfHamburgGermany

4. UKE Microscopy Imaging FacilityUniversity Medical Center Hamburg‐EppendorfHamburgGermany

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201302979

Reference58 articles.

1. Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1

2. Bovine UDP-N-acetylglucosamine:Lysosomal-enzyme N-Acetylglucosamine-1-phosphotransferase I

3. When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients

4. Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway.

5. Vacuolization of mucolipidosis type II mouse exocrine gland cells represents accumulation of autolysosomes

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative-Stress-Related Genes in Osteoporosis: A Systematic Review;Antioxidants;2023-04-12

2. Secondary Hyperparathyroidism in Children with Mucolipidosis Type II (I-Cell Disease): Irish Experience;Journal of Clinical Medicine;2022-03-02

3. Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III;Genetics in Medicine;2021-12

4. “Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients”;Molecular Genetics and Metabolism Reports;2021-09

5. Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene;Journal of Genetic Engineering and Biotechnology;2021-08-03